[go: up one dir, main page]

SI0839159T1 - Polysaccharide gel composition - Google Patents

Polysaccharide gel composition

Info

Publication number
SI0839159T1
SI0839159T1 SI9630349T SI9630349T SI0839159T1 SI 0839159 T1 SI0839159 T1 SI 0839159T1 SI 9630349 T SI9630349 T SI 9630349T SI 9630349 T SI9630349 T SI 9630349T SI 0839159 T1 SI0839159 T1 SI 0839159T1
Authority
SI
Slovenia
Prior art keywords
cross
polysaccharide
linking
gel composition
gel
Prior art date
Application number
SI9630349T
Other languages
English (en)
Slovenian (sl)
Inventor
Med Ab Q
Original Assignee
Med Ab Q
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24001615&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI0839159(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Med Ab Q filed Critical Med Ab Q
Publication of SI0839159T1 publication Critical patent/SI0839159T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Materials For Medical Uses (AREA)
  • Colloid Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SI9630349T 1995-07-17 1996-05-28 Polysaccharide gel composition SI0839159T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/503,323 US5827937A (en) 1995-07-17 1995-07-17 Polysaccharide gel composition
EP96923119A EP0839159B1 (en) 1995-07-17 1996-05-28 Polysaccharide gel composition
PCT/SE1996/000684 WO1997004012A1 (en) 1995-07-17 1996-05-28 Polysaccharide gel composition

Publications (1)

Publication Number Publication Date
SI0839159T1 true SI0839159T1 (en) 2002-04-30

Family

ID=24001615

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9630349T SI0839159T1 (en) 1995-07-17 1996-05-28 Polysaccharide gel composition

Country Status (25)

Country Link
US (1) US5827937A (xx)
EP (1) EP0839159B1 (xx)
JP (1) JP3094074B2 (xx)
KR (1) KR100314488B1 (xx)
CN (1) CN1083849C (xx)
AT (1) ATE204000T1 (xx)
BR (2) BRPI9609534B8 (xx)
CA (1) CA2226488C (xx)
CZ (1) CZ290755B6 (xx)
DE (2) DE839159T1 (xx)
DK (1) DK0839159T3 (xx)
EA (1) EA001500B1 (xx)
ES (1) ES2161368T3 (xx)
GR (1) GR3037065T3 (xx)
HU (1) HU220257B (xx)
MX (1) MX9800484A (xx)
NO (1) NO315274B1 (xx)
NZ (1) NZ312229A (xx)
PL (1) PL188071B1 (xx)
PT (1) PT839159E (xx)
SI (1) SI0839159T1 (xx)
SK (1) SK282431B6 (xx)
TR (1) TR199800072T1 (xx)
UA (1) UA48980C2 (xx)
WO (1) WO1997004012A1 (xx)

Families Citing this family (165)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7060287B1 (en) 1992-02-11 2006-06-13 Bioform Inc. Tissue augmentation material and method
US7968110B2 (en) * 1992-02-11 2011-06-28 Merz Aesthetics, Inc. Tissue augmentation material and method
US6537574B1 (en) 1992-02-11 2003-03-25 Bioform, Inc. Soft tissue augmentation material
US6193994B1 (en) * 1996-05-23 2001-02-27 Samyang Corporation Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
US7192984B2 (en) * 1997-06-17 2007-03-20 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use as dermal fillers
EP0999854B1 (en) 1997-07-29 2003-10-01 Alcon Manufacturing Ltd. Switchable viscoelastic systems containing galactomannan polymers and borate
GB9902412D0 (en) 1999-02-03 1999-03-24 Fermentech Med Ltd Process
GB9902652D0 (en) 1999-02-05 1999-03-31 Fermentech Med Ltd Process
US8188043B2 (en) * 1999-07-28 2012-05-29 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
KR100721752B1 (ko) 2000-01-24 2007-05-25 쿠라레 메디카루 가부시키가이샤 수팽윤성 고분자 겔 및 그 제조법
SE0004928D0 (sv) * 2000-12-29 2000-12-29 Apbiotech Ab A method for the manufacturing of porous material
FR2819722B1 (fr) * 2001-01-19 2006-11-24 Corneal Ind Utilisation de l'acide hyaluronique ou d'au moins l'un de ses sels dans le cadre d'un traitemnet chirurgical de la presbytie
US8580290B2 (en) 2001-05-08 2013-11-12 The Board Of Regents Of The University Of Oklahoma Heparosan-based biomaterials and coatings and methods of production and use thereof
US20070078435A1 (en) * 2001-06-14 2007-04-05 Corbett Stone Tissue augmentation methods using a medical injection apparatus
WO2003054077A1 (en) 2001-12-11 2003-07-03 Ceapro Inc. Cereal beta glucan compositions, methods of preparation and uses thereof
KR20040009891A (ko) * 2002-07-26 2004-01-31 주식회사 엘지생명과학 히알루론산의 유도체 겔 및 그 제조방법
EP1564220A4 (en) * 2002-11-21 2010-03-17 Chugai Pharmaceutical Co Ltd EXCIPIENT FOR DELAYED RELEASE MEDICINE
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
AU2003901834A0 (en) * 2003-04-17 2003-05-01 Clearcoll Pty Ltd Cross-linked polysaccharide compositions
JP2004323454A (ja) * 2003-04-25 2004-11-18 Chisso Corp 薬剤
AU2004261752B2 (en) * 2003-07-30 2010-10-28 Anteis S.A. Complex matrix for biomedical use
EP1681306B1 (en) * 2003-10-29 2013-02-20 Teijin Limited Hyaluronic acid compound, hydrogel thereof and material for treating joint
EP1683812B1 (en) * 2003-11-14 2014-11-12 Chugai Seiyaku Kabushiki Kaisha Crosslinked polysaccharide microparticles and method for their preparation
US8124120B2 (en) * 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
US8524213B2 (en) * 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
FR2865737B1 (fr) * 2004-02-03 2006-03-31 Anteis Sa Gel reticule biocompatible
US20050226936A1 (en) 2004-04-08 2005-10-13 Q-Med Ab Method of soft tissue augmentation
SE0401182D0 (sv) * 2004-05-05 2004-05-05 Q Med Ab Novel use of a viscoelastic composition
WO2005113608A1 (en) 2004-05-20 2005-12-01 Mentor Corporation Method of covalently linking hyaluronan and chitosan
FR2871692B1 (fr) * 2004-06-22 2007-08-03 Epitact Md Sa Procede et dispositif pour accelerer la croissance des phaneres, notamment des ongles
TW200612991A (en) * 2004-09-07 2006-05-01 Chugai Pharmaceutical Co Ltd Process for producing water-soluble hyaluronic acid modification
US20060105022A1 (en) * 2004-11-15 2006-05-18 Shiseido Co., Ltd. Process for preparing crosslinked hyaluronic acid gel
JP4875988B2 (ja) * 2004-11-15 2012-02-15 株式会社 資生堂 架橋ヒアルロン酸ゲルの製造方法
CA2744999A1 (en) 2004-12-30 2006-07-13 Genzyme Corporation Regimens for intra-articular viscosupplementation
MX2007013725A (es) 2005-05-05 2008-04-09 Sensient Flavors Inc Produccion de beta-glucanos y mananos.
US20070003584A1 (en) * 2005-06-16 2007-01-04 Russell Anderson Liquid crystal polymer syringes and containers and methods of use for long term storage of filler materials
KR101250846B1 (ko) * 2005-07-04 2013-04-05 주식회사 엘지생명과학 히알루론산 가교물의 제조방법
US20070102010A1 (en) * 2005-10-07 2007-05-10 Lemperle Stefan M Naso-pharyngeal tissue engineering
CN100379763C (zh) * 2006-01-12 2008-04-09 武汉大学 交联茯苓多糖及其制备方法和用途
US20070184087A1 (en) * 2006-02-06 2007-08-09 Bioform Medical, Inc. Polysaccharide compositions for use in tissue augmentation
US20070212385A1 (en) * 2006-03-13 2007-09-13 David Nathaniel E Fluidic Tissue Augmentation Compositions and Methods
DE102006013594A1 (de) * 2006-03-22 2007-09-27 Biopolymer Gmbh & Co. Kg Quervernetzte Gele von Hyaluronsäure und deren Verwendung
US8378064B2 (en) * 2006-05-19 2013-02-19 Trustees Of Boston University Hydrophilic polymers as medical lubricants and gels
FR2909285A1 (fr) * 2006-12-01 2008-06-06 Anteis Sa "utilisation d'un gel anti-adhesif et anti fibrotique"
WO2008136536A1 (ja) 2007-05-01 2008-11-13 National University Corporation Tokyo Medical And Dental University 化学架橋ヒアルロン酸誘導体を含むハイブリッドゲルおよびそれを用いた医薬組成物
WO2008143681A1 (en) * 2007-05-16 2008-11-27 Medicis Pharmaceutical Corporation Methods for identifying areas of a subject's skin that appear to lack volume
US8658148B2 (en) 2007-06-22 2014-02-25 Genzyme Corporation Chemically modified dendrimers
FR2918377B1 (fr) * 2007-07-05 2010-10-08 Estelle Piron Gel co-reticule de polysaccharides
WO2009012367A1 (en) * 2007-07-18 2009-01-22 Aesthetic Science Composition and method of use for soft tissue augmentation/drug delivery
WO2009018546A1 (en) * 2007-08-02 2009-02-05 Medicis Pharmaceutical Corporation Method of applying an injectable filler
US20090204101A1 (en) * 2007-08-20 2009-08-13 Wortzman Mitchell S Method of applying an injectable filler
EP2199308B1 (en) 2007-09-28 2012-02-08 Shiseido Company, Ltd. Swellable crosslinked hyaluronic acid powder and method for producing the same
US8703119B2 (en) * 2007-10-05 2014-04-22 Polygene Ltd. Injectable biodegradable polymer compositions for soft tissue repair and augmentation
BRPI0819075A2 (pt) 2007-11-16 2014-10-07 Vicept Therapeutics Inc Método para tratar púrpura em um indivíduo e método para diminuir a púrpura em um indivíduo antes de um procedimento cirúrgico
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US20090143348A1 (en) * 2007-11-30 2009-06-04 Ahmet Tezel Polysaccharide gel compositions and methods for sustained delivery of drugs
US9925209B2 (en) 2008-03-19 2018-03-27 The Board Of Regents Of The University Of Oklahoma Heparosan-polypeptide and heparosan-polynucleotide drug conjugates and methods of making and using same
US9687559B2 (en) 2008-03-19 2017-06-27 The Board Of Regents Of The University Of Oklahoma Heparosan polymers and methods of making and using same for the enhancement of therapeutics
GB2469219A (en) * 2008-04-10 2010-10-06 Kythera Biopharmaceuticals Inc Dermal filler composition
US8932622B2 (en) * 2008-06-03 2015-01-13 Actamax Surgical Materials, Llc Tissue coating for preventing undesired tissue-to-tissue adhesions
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
US9228027B2 (en) 2008-09-02 2016-01-05 Allergan Holdings France S.A.S. Threads of Hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
CN101445566B (zh) * 2008-12-11 2011-05-04 彭秀兰 No增放剂精氨酸氨基多糖及其生产方法
US9173975B2 (en) 2009-04-24 2015-11-03 Ingeneron, Inc. Reparative cell delivery via hyaluronic acid vehicles
IT1395392B1 (it) 2009-08-27 2012-09-14 Fidia Farmaceutici Geli viscoelastici come nuovi filler
US8273725B2 (en) 2009-09-10 2012-09-25 Genzyme Corporation Stable hyaluronan/steroid formulation
JP2013509963A (ja) 2009-11-09 2013-03-21 スポットライト テクノロジー パートナーズ エルエルシー 断片化ヒドロゲル
WO2011057131A1 (en) 2009-11-09 2011-05-12 Spotlight Technology Partners Llc Polysaccharide based hydrogels
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
KR101764451B1 (ko) 2010-03-12 2017-08-02 알러간 인더스트리 에스에이에스 피부 상태 개선을 위한 히알루론안 폴리머 및 만니톨을 포함하는 유체 조성물
CA2794254C (en) 2010-03-22 2018-09-04 Allergan, Inc. Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
JP5684903B2 (ja) * 2010-06-08 2015-03-18 ダウ グローバル テクノロジーズ エルエルシー 粒状の可逆的に架橋したポリマー材料の調製方法
CA2805008C (en) 2010-07-12 2015-05-12 Shin Poong Pharmaceutical Co., Ltd. Filler composition for tissue augmentation comprising a hydrogel of hyaluronic acid cross-linked with alkylene diamine
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
WO2012027834A1 (en) * 2010-09-02 2012-03-08 Mcmaster University Hyaluronic acid-containing biopolymers
FR2968996B1 (fr) 2010-12-17 2013-04-12 Anteis Sa Formulation aqueuse injectable sterile utilisee en ophtalmologie
EP2484387A1 (en) * 2011-02-03 2012-08-08 Q-Med AB Hyaluronic acid composition
EP2691115A1 (en) 2011-03-31 2014-02-05 Galderma Research & Development Compositions comprising a filler product and at least one bioresorbable and biodegradable silica-based material
WO2012146031A1 (zh) * 2011-04-26 2012-11-01 北京爱美客生物科技有限公司 透明质酸与羟丙基甲基纤维素复合凝胶及制备方法
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
AU2012262047A1 (en) 2011-06-03 2014-01-16 Allergan, Inc. Dermal filler compositions including antioxidants
CN103796689B (zh) 2011-07-28 2017-05-31 哈博医疗科技有限公司 交联的人或动物组织产品及其制造方法和使用方法
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
EP2581079B1 (en) * 2011-10-11 2016-12-07 BioPolymer GmbH & Co. KG Combination of hyaluronic acid and prilocaine
ITAN20110138A1 (it) 2011-10-12 2012-01-11 Regenyal Lab S R L Sintesi di un gel iniettabile multifasico a base di acido ialuronico monofasico libero e reticolato e di acido ialuronico bifasico associato con idrossiapatite con inibitore della ialuronidasi microincapsulato.
JP2014521492A (ja) * 2011-11-11 2014-08-28 エムアイビーエイ メディカル インコーポレイテッド 注入充填剤（フィラー）｛ｉｎｊｅｃｔａｂｌｅｆｉｌｌｅｒ｝
ES2645082T3 (es) 2012-03-12 2017-12-04 The Regents Of The University Of California Métodos y composiciones de tratamiento de heridas y reducción del riesgo de hernias incisionales
KR101240518B1 (ko) 2012-03-26 2013-03-11 주식회사 제네웰 생체 적합성 고분자를 이용한 이식용 재료
WO2013149161A1 (en) 2012-03-30 2013-10-03 Deangelis Paul L High molecular weight heparosan polymers and methods of production and use thereof
CN102614111B (zh) * 2012-04-05 2013-11-06 苏州豫源生物医药有限公司 氨基葡萄糖的凝胶剂及其制备方法
ITMI20120732A1 (it) 2012-05-03 2013-11-04 B S Srl Polisaccaridi reticolati a memoria di forma
ITPD20120173A1 (it) 2012-05-31 2013-12-01 Fidia Farmaceutici "nuovo sistema di rilascio di proteine idrofobiche"
EP2861626B1 (en) 2012-06-15 2018-12-19 Merz Pharma GmbH & Co. KGaA Method of preparing a composition based on hyaluronic acid
JP5840107B2 (ja) 2012-06-17 2016-01-06 コスメディ製薬株式会社 ヒアルロン酸ゲル及びその製造方法
US20150352142A1 (en) 2013-01-11 2015-12-10 Carbylan Therapeutics, Inc. Stabilized compositions comprising hyaluronic acid
CN103146003A (zh) * 2013-03-06 2013-06-12 上海其胜生物制剂有限公司 一种低温二次交联透明质酸钠凝胶的制备方法
KR101869988B1 (ko) * 2013-03-27 2018-06-21 주식회사 엘지화학 점탄성 히알루론산 가교물 제조용 조성물, 및 이를 이용하여 얻은 히알루론산 가교물
DK2996709T3 (da) 2013-05-15 2020-06-02 Univ Leland Stanford Junior Modulering af herpan-bindende epidermal vækstfaktoraktivitet til heling af trommehinde
WO2014198406A1 (en) 2013-06-11 2014-12-18 Anteis S.A. Method for crosslinking hyaluronic acid; method for preparing an injectable hydrogel; hydrogel obtained; use of the obtained hydrogel
HK1224315A1 (zh) * 2013-06-28 2017-08-18 Galderma S.A. 用於制备交联的透明质酸产物的方法
BR112015031589A2 (pt) * 2013-06-28 2017-07-25 Galderma Sa método para a fabricação de um produto moldado de ácido hialurônico reticulado
EP3017808B1 (en) 2013-07-03 2022-07-13 Ritapharma, Co., Ltd. Water-soluble hyaluronic acid gel and method for producing same
EP3052529B1 (en) 2013-09-30 2017-10-04 Galderma S.A. Single-step functionalization and cross-linking of hyaluronic acid
KR101459070B1 (ko) 2013-12-09 2014-11-17 (주) 뉴메딕 지속성을 갖는 히알루론산 겔 조성물
AR099900A1 (es) 2014-04-01 2016-08-24 Merz Pharma Gmbh & Co Kgaa Rellenos para tejidos blandos con polisacáridos con persistencia mejorada, kit, procedimiento, uso
WO2015181369A1 (en) 2014-05-29 2015-12-03 Galderma S.A. Cross-linked hyaluronic acid grafted with dextran
WO2015181366A1 (en) * 2014-05-29 2015-12-03 Galderma S.A. Cross-linked polymer mixture of hyaluronic acid and dextran grafted with cyclodextrins and uses thereof
US9908948B2 (en) 2014-08-29 2018-03-06 Galderma S.A. Enantiopure or enantioenriched BDDE and its use as crosslinking agent in the manufacture of cross-linked products
EP3620184A1 (en) 2014-09-30 2020-03-11 Allergan Industrie, SAS Stable hydrogel compositions including additives
US20170290947A1 (en) * 2014-10-08 2017-10-12 Therakine Bio Delivery GmbH Micronized hydrophilic cross-linked biopolymer systems and method of making same
CN107428851A (zh) 2014-12-18 2017-12-01 盖尔德玛公司 通过酰胺键将环糊精接枝至醚交联的透明质酸及其用途
EP3040118A1 (en) 2014-12-29 2016-07-06 Galderma S.A. Ether cross-linked chondroitin hydrogels and their use for soft tissue applications
EP3040348A1 (en) 2014-12-29 2016-07-06 Galderma S.A. Graft copolymer
EP3040117A1 (en) 2014-12-29 2016-07-06 Galderma S.A. Ether cross-linked chondroitin sulfate hydrogels and their use for soft tissue applications
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
KR102759640B1 (ko) 2015-02-13 2025-01-23 알러간 인더스트리 에스에이에스 턱과 같은 얼굴 이목구비를 조각, 확대 또는 교정하기 위한 임플란트
US10004824B2 (en) 2015-05-11 2018-06-26 Laboratoires Vivacy Compositions comprising at least one polyol and at least one anesthetic
EP3302591B1 (en) 2015-05-29 2020-12-30 Galderma S.A. Mixed hydrogels of hyaluronic acid and dextran
EP3307237A1 (en) 2015-06-12 2018-04-18 Laboratoire Français du Fractionnement et des Biotechnologies Injectable composition of factor vii and fillers
FR3037797B1 (fr) 2015-06-24 2018-08-17 Kylane Laboratoires Sa Procede de preparation d'un hydrogel reticule injectable; hydrogel obtenu; utilisation de l'hydrogel obtenu
US9737395B2 (en) 2015-06-26 2017-08-22 Phi Nguyen Systems and methods for reducing scarring
EP3316911B1 (en) 2015-06-30 2020-11-04 Merz Pharma GmbH & Co. KGaA Method of preparing a composition based on hyaluronic acid
KR20170025778A (ko) 2015-08-31 2017-03-08 대화제약 주식회사 항산화제를 포함하는 생체 적합성 고분자 히알루론산 유도체 및 그 히알루론산의 가교결합물
KR101720426B1 (ko) 2015-09-01 2017-04-14 (주)시지바이오 히알루론산 조성물 및 그의 제조방법
CN105126157B (zh) * 2015-09-17 2018-02-09 爱美客技术发展股份有限公司 医用可注射粘合凝胶及其制备方法
FR3044557B1 (fr) 2015-12-07 2017-12-01 Benedicte Vincente Gavard Molliard Tauzin Nouvelle composition injectable; procede de preparation de ladite composition; utilisation de ladite composition
FR3047666A1 (fr) 2016-02-15 2017-08-18 Benedicte Vincente Gavard Molliard Tauzin Composition injectable; procede de preparation de ladite composition; utilisation de ladite composition
KR101866310B1 (ko) 2016-05-31 2018-06-11 주식회사 글랜젠 생체 내 지속성 및 항산화 작용이 향상된 진피 충전재 조성물 및 이의 제조방법
EP3475312B1 (en) 2016-06-23 2020-05-27 Galderma S.A. Cyclodextrin-grafted cross-linked hyaluronic acid complexed with active drug substances and uses thereof
ES2901326T3 (es) 2016-08-03 2022-03-22 Galderma Res & Dev Procedimiento de reticulación de glicosaminoglicanos
KR20190070327A (ko) 2016-09-21 2019-06-20 네슬레 스킨 헬스 소시에떼 아노님 2가 아연 양이온을 갖는 히알루론산 겔
AR110125A1 (es) 2016-11-07 2019-02-27 Croma Pharma Ges M B H Compuestos poliméricos que liberan sulfuro de hidrógeno
EP3494146A1 (en) 2016-12-23 2019-06-12 Galderma Research & Development Double crosslinked glycosaminoglycans
EP3494145B1 (en) 2016-12-23 2020-05-20 Galderma Research & Development Method of crosslinking glycosaminoglycans
WO2018122342A1 (en) 2016-12-29 2018-07-05 Nestlé Skin Health Sa Micro- or nanoparticular multilamellar vesicles, compositions comprising the same and method for their use in skin care
WO2018122344A1 (en) 2016-12-29 2018-07-05 Nestlé Skin Health Sa Composition comprising a crosslinked hyaluronic acid (ha) in combination with a low-molecular ha and/or an agent stimulating endogenous ha synthesis
EP3562469A1 (en) 2016-12-29 2019-11-06 Nestlé Skin Health SA Micro- or nanoparticular vesicles comprising crosslinked hyaluronic acid, compositions comprising the same and method for their use in skin care
IT201700008651A1 (it) 2017-01-26 2018-07-26 Beauty System Pharma Ltd Acido ialuronico reticolato con agenti reticolanti di tipo naturale o semisintetico
CN108721206B (zh) * 2017-04-14 2021-11-09 常州药物研究所有限公司 治疗膀胱输尿管返流、压力性尿失禁和大便失禁的组合物及其制备方法
WO2018220283A1 (fr) 2017-05-29 2018-12-06 Kh Medtech Sarl Composition injectable sterile contenant de l'acide hyaluronique reticule et de l'articaine
WO2019001784A1 (en) 2017-06-28 2019-01-03 Nestlé Skin Health Sa Hyaluronic acid gel with a divalent cation
WO2019002371A1 (en) 2017-06-28 2019-01-03 Nestlé Skin Health Sa GLYCOSAMINOGLYCAN GEL WITH BIS-TRIS BUFFER
WO2019121694A1 (en) 2017-12-22 2019-06-27 Nestlé Skin Health Sa Injectable compositions of cross-linked hyaluronic acid and bupivacaine, and uses thereof
IL278370B2 (en) 2018-05-03 2024-02-01 Collplant Ltd Dermal fillers and their uses
CA3105709C (en) 2018-07-06 2024-03-12 Lg Chem, Ltd. Hyaluronic acid filler having high viscoelasticity and high cohesiveness
EP3804770B1 (en) 2018-07-10 2023-12-06 Lg Chem, Ltd. Hyaluronic acid filler having high lift capacity and low injection force
KR20200046649A (ko) 2018-10-25 2020-05-07 (주)뉴크레이티브랩 혼합상 히알루론산 제조방법
KR102334794B1 (ko) 2018-12-20 2021-12-03 주식회사 엘지화학 우수한 필러 특성을 갖는 히알루론산 하이드로겔을 포함하는 필러
CA3121313C (en) 2018-12-21 2023-07-18 Lg Chem, Ltd. Filler comprising hyaluronic acid hydrogel having excellent filling properties
ES2969884T3 (es) 2019-04-02 2024-05-23 Volumina Medical Sa Composición que comprende un poliol reticulado
TR201922945A2 (tr) * 2019-12-31 2021-07-26 Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi Osteoartri̇t tedavi̇si̇ i̇çi̇n propoli̇s i̇çeri̇kli̇ yeni̇ bi̇r vi̇skoelasti̇k formülasyonu ve bunun üreti̇m yöntemi̇
WO2021222752A1 (en) 2020-05-01 2021-11-04 Harbor Medtech, Inc. Port-accessible multidirectional reinforced minimally invasive collagen device for soft tissue repair
KR102425496B1 (ko) 2020-05-08 2022-07-26 주식회사 종근당 고탄성, 고점도 및 고유효 가교율을 갖는 히알루론산 가교체, 및 이의 제조방법
US20240269349A1 (en) 2021-09-09 2024-08-15 Sunbio Inc. Sol-gel conversion over time of 6-arm peg hydrogel
IT202100032111A1 (it) 2021-12-22 2023-06-22 Fidia Farm Spa Nuovi sostituti biocompatibili dell’umor vitreo
EP4473021A1 (en) 2022-02-01 2024-12-11 Galderma Holding SA Methods of producing crosslinked hyaluronic acid hydrogels
US12312447B2 (en) 2023-06-19 2025-05-27 Zhejiang Triple Win New Material Co., Ltd. Preparation method for polysaccharide spherical gel resin
WO2025086125A1 (en) 2023-10-25 2025-05-01 L'oreal Composition for conditioning keratin fibers

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197846A (en) * 1974-10-09 1980-04-15 Louis Bucalo Method for structure for situating in a living body agents for treating the body
US4716224A (en) * 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
GB8412423D0 (en) * 1984-05-16 1984-06-20 Allied Colloids Ltd Polymeric compositions
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
US4863907A (en) * 1984-06-29 1989-09-05 Seikagaku Kogyo Co., Ltd. Crosslinked glycosaminoglycans and their use
US5128326A (en) * 1984-12-06 1992-07-07 Biomatrix, Inc. Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
SE458525B (sv) * 1985-05-23 1989-04-10 Pharmacia Ab Foerfarande foer tvaerbindning av en poroes agar- eller agarosgel
SE452469B (sv) * 1986-06-18 1987-11-30 Pharmacia Ab Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma
US4803075A (en) * 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US4767463A (en) * 1987-04-15 1988-08-30 Union Carbide Corporation Glycosaminoglycan and cationic polymer combinations
US5017229A (en) * 1990-06-25 1991-05-21 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US5007940A (en) * 1989-06-09 1991-04-16 American Medical Systems, Inc. Injectable polymeric bodies
US5143724A (en) * 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
US5246698A (en) * 1990-07-09 1993-09-21 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
DE784487T1 (de) * 1993-03-19 1999-11-04 Q-Med Ab, Uppsala Ein präparat und ein verfahren zur gewebevermehrung

Also Published As

Publication number Publication date
SK282431B6 (sk) 2002-02-05
CN1083849C (zh) 2002-05-01
SK6198A3 (en) 1999-01-11
BRPI9609534B8 (pt) 2020-05-12
DE69614391D1 (de) 2001-09-13
HUP9901714A3 (en) 2000-06-28
PT839159E (pt) 2001-11-30
NO980213L (no) 1998-03-16
CA2226488A1 (en) 1997-02-06
CZ290755B6 (cs) 2002-10-16
WO1997004012A1 (en) 1997-02-06
TR199800072T1 (xx) 1998-05-21
US5827937A (en) 1998-10-27
DK0839159T3 (da) 2001-10-08
ATE204000T1 (de) 2001-08-15
MX9800484A (es) 1998-04-30
BR9609534A (pt) 1999-02-23
PL324608A1 (en) 1998-06-08
DE839159T1 (de) 1999-10-07
AU6371896A (en) 1997-02-18
NO315274B1 (no) 2003-08-11
UA48980C2 (uk) 2002-09-16
KR19990029034A (ko) 1999-04-15
CZ12998A3 (cs) 1998-06-17
JPH11509256A (ja) 1999-08-17
DE69614391T2 (de) 2002-02-14
NO980213D0 (no) 1998-01-16
GR3037065T3 (en) 2002-01-31
PL188071B1 (pl) 2004-12-31
HU220257B (hu) 2001-11-28
AU700215B2 (en) 1998-12-24
EA001500B1 (ru) 2001-04-23
CA2226488C (en) 2005-12-06
BR9609534B1 (pt) 2010-07-27
JP3094074B2 (ja) 2000-10-03
ES2161368T3 (es) 2001-12-01
KR100314488B1 (ko) 2001-12-28
CN1190974A (zh) 1998-08-19
HUP9901714A2 (hu) 1999-09-28
EA199800133A1 (ru) 1998-10-29
EP0839159B1 (en) 2001-08-08
NZ312229A (en) 1998-11-25
EP0839159A1 (en) 1998-05-06

Similar Documents

Publication Publication Date Title
NZ312229A (en) Cross-linked biocompatible polysaccharide gel composition
NO955315L (no) Fremgangsmåte for fremstilling av vandige polymeremulsjoner
CA2076732A1 (en) Modified polysaccharides having improved absorbent properties and process for the preparation thereof
WO2000049084A8 (en) Hyaluronic acid gel composition, process for producing the same, and medical material containing the same
AU2001229740A1 (en) Polymers containing modified pigments and methods of preparing the same
CA2237192A1 (en) Photocured crosslinked-hyaluronic acid gel and method of preparation thereof
AU7405591A (en) Biocompatible viscoelastic gel slurries, their preparation and use
AU4682899A (en) Alkali soluble latex thickeners
ATE407151T1 (de) In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung
EP1545605B8 (en) Composition for vaccination
ZA966149B (en) Photochemically cross-linked polysaccharide derivatives having no photopolymerisable functional groups
EP1078936A3 (en) Process for stripping polymer dispersions or solutions
CA2165494A1 (en) Composition and method for inhibiting coal oxidation
RU2382050C1 (ru) Способ получения модифицированной аскорбиновой кислотой сшитой соли гиалуроновой кислоты и биоактивная композиция на ее основе
WO2004111188A3 (en) Process for the treatment of chitinaceous materials and for the deacetylation of chitin
DK1085920T3 (da) Dextrinholdigt præparat til forebyggelse af kirurgiske adhæsioner
EP0402605A3 (en) Cellulose aminomethanate by acid neutralization
AU3689789A (en) Method upon a temperature increase of counteracting a viscosity decrease or providing a viscosity increase in a water-base system containing a polymer as viscosity agent
AU1967699A (en) Method for preparing an aqueous polymer dispersion, resulting aqueous dispersionand use thereof
JP2002128899A (ja) 生分解性を有する吸水性高分子
WO2003020221A3 (en) Method of treating cancerous disease
MX9605199A (es) Composiciones acuosas de revestimiento.
EP1471080A3 (en) Process for stripping polymer dispersions or solutions
ATE207499T1 (de) Verfahren zur herstellung von cellulose-derivaten
Kurbatova et al. Preparation of hydrolytically stable iron-dextran micro particles